Bovie Medical Corporation to Release Third Quarter 2017 Financial Results on November 2, 2017
October 17 2017 - 4:05PM
Business Wire
Bovie Medical (NYSE American: BVX), a maker of medical
devices and supplies and the developer of J-Plasma®, a patented new
surgical product, today announced that financial results for the
third quarter of 2017 will be released after the market closes on
Thursday, November 2.
Management will host a conference call at 4:30 p.m. Eastern Time
on November 2 to discuss the results of the quarter and host a
question and answer session. To listen to the call by phone,
interested parties may dial 844-507-6493 (or 647-253-8641 for
international callers) and provide access code 95898318.
Participants should ask for the Bovie Medical Corporation Call. A
live webcast of the call will be accessible via the Investor
Relations section of the Company’s website and
at: https://event.on24.com/wcc/r/1472820/04D7A7087BD18CA1B64C4A121242427B.
A telephonic replay will be available approximately two hours
after the end of the call through November 16, 2017. The replay can
be accessed by dialing 800-585-8367 for U.S. callers or
416-621-4642 for International callers and using the replay access
code: 95898318. The webcast will be archived on the Investor
Relations section of the Company's website.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices
and supplies as well as the developer of J-Plasma®, a patented
plasma-based surgical product for cutting, coagulation and ablation
of soft tissue. J-Plasma® utilizes a helium ionization process to
produce a stable, focused beam of plasma that provides surgeons
with greater precision, minimal invasiveness and an absence of
conductive currents through the patient during surgery. The new
J-Plasma® handpieces with Cool-Coag™ technology deliver the
precision of helium plasma energy, the power of traditional
monopolar coagulation and the efficiency of plasma beam coagulation
– enabling thin-layer ablation and dissection and fast coagulation
with a single instrument, minimizing instrument exchange and
allowing a surgeon to focus on their patient and their procedures.
With Cool-Coag technology, the new J-Plasma handpieces can deliver
three distinctly different energy modalities – further increasing
the utility and versatility of the J-Plasma system. Bovie Medical
Corporation is also a leader in the manufacture of a range of
electrosurgical products and technologies, marketed through both
private labels and the Company’s own well-respected brands (Bovie®,
IDS™ and DERM™) to distributors worldwide. The Company also
leverages its expertise through original equipment manufacturing
(OEM) agreements with other medical device manufacturers. For
further information about the Company’s current and new products,
please refer to the Investor Relations section of Bovie Medical
Corporation at www.boviemedical.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171017006605/en/
Investor Relations:Westwicke PartnersMike Piccinino,
CFAManaging Director443-213-0500investor.relations@boviemed.com
Bovie (AMEX:BVX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bovie (AMEX:BVX)
Historical Stock Chart
From Sep 2023 to Sep 2024